What does bioavailability of a drug mean?

What does bioavailability of a drug mean?

(BY-oh-uh-VAY-luh-bul) The ability of a drug or other substance to be absorbed and used by the body. Orally bioavailable means that a drug or other substance that is taken by mouth can be absorbed and used by the body.

Is bioequivalence the same as bioavailability?

Bioavailability is a measurement of the rate and extent to which a therapeutically active chemical is absorbed from a drug product into the systemic circulation and becomes available at the site of action. If two drugs are bioequivalent, there is no clinically significant difference in their bioavailability.

What determines bioequivalence?

Bioequivalence is determined based on the relative bioavailability of the innovator medicine versus the generic medicine. It is measured by comparing the ratio of the pharmacokinetic variables for the innovator versus the generic medicine where equality is 1.

What is BA and BE studies?

BA/BE (Bioavailability & Bioequivalence) Studies. Bioequivalence is a term in pharmacokinetics used to assess the expected in vivo biological equivalence of generic version to its proprietary version of a drug or formulations of innovator drug in different clinical trial phases.

What is the difference between absorption and bioavailability?

It is suggested that absorption be defined as movement of drug across the outer mucosal membranes of the GI tract, while bioavailability be defined as availability of drug to the general circulation or site of pharmacological actions.

What does higher bioavailability mean?

Bioavailability is the degree to which a nutrient is available to the body for use and measures the rate that a supplement is absorbed within the body after it has been administered. …

What makes a drug bioequivalent?

Two drug products are said to be bioequivalent if they are pharmaceutical equivalents (i.e., similar dosage forms made, perhaps, by different manufacturers) or pharmaceutical alternatives (i.e., different dosage forms) and if their rates and extents of absorption do not show a significant difference to which the active …

What are main differences between bioavailability and bioequivalence studies?

Bioavailability studies focus on determining the process and time frame by which a drug substance is released from the oral dosage form and moves to the site of action. On the other hand, bioequivalence studies focus on the performance of the drug product and usually involve comparisons of two drug products: T and R.

What does bioavailability mean in pharmacology?

Bioavailability refers to the extent and rate at which the active moiety (drug or metabolite) enters systemic circulation, thereby accessing the site of action. Bioavailability of a drug is largely determined by the properties of the dosage form, which depend partly on its design and manufacture.

How do you measure drug bioavailability?

Bioavailability is assessed using two main pharmacokinetic variables (see Figure 1): • the area under the blood concentration versus time curve (AUC) • the maximum blood concentration (C. max. ). Bioequivalence. If two drugs are bioequivalent, there is no clinically significant difference in their bioavailability.

How is the bioavailability of an oral formulation determined?

Since the AUC is a measure of the total amount of unaltered drug that reaches the systemic circulation (see Section VI.A .), the bioavailability of the oral formulation can subsequently be determined by comparing these respective AUCs, as described by the following equation:

What is relative bioavailability and how is It measured?

This is referred to as measuring relative bioavailability, and it provides a measure of the relative performance of two formulations (new formulation A and reference formulation B) in getting the drug absorbed into the systemic circulation (see Equation 23.10 ).